Hyman, Phelps & McNamara, P.C. (HP&M) is proud to announce that two associates, Serra Schlanger and Rachael Hunt, will be hosting a program on telemedicine for FDLI’s New to Food and Drug Law Group (NFDL).
Telemedicine: Key Issues to Consider When Advising Clients, will take place on March 7, 2019 from 12pm – 1:30pm at HP&M in Washington, D.C. Telemedicine, the use of telecommunication technology to remotely provide health care services, is an emerging interest for clients in the FDA sector. For example, many FDA-regulated companies are now using internet platforms to engage with patients and potential customers. The use of the internet in this context touches on FDA regulations, state law requirements, and a host of other issues. This program will introduce subjects to consider when working with clients interested in exploring telemedicine as a new business opportunity or as a component of an existing platform.
For additional information, including a link to register, please visit this website.